To include your compound in the COVID-19 Resource Center, submit it here.

CVBT-141B: Phase IIb data

In a double-blind Phase IIb trial, diabetic wounds treated with CVBT-141B achieved 100%

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE